Covered recipient · General Payments record
TERESA A WILLIAMSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,678.66
- Reported across 105 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $291.12 | 16 |
| Education | $8.90 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $150.99 | 8 |
| Abbott Laboratories | $85.40 | 6 |
| ABBVIE INC. | $63.63 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $13.15 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125215598 | CMS |
| Abbott Laboratories | $13.83 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125215600 | CMS |
| Abbott Laboratories | $13.83 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125215602 | CMS |
| Abbott Laboratories | $14.35 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125215604 | CMS |
| Abbott Laboratories | $15.10 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125215606 | CMS |
| Abbott Laboratories | $15.14 | 12/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125215608 | CMS |
| ABBVIE INC. | $19.87 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106343344 | CMS |
| ABBVIE INC. | $24.72 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106343346 | CMS |
| ABBVIE INC. | $19.04 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106343348 | CMS |
| Novo Nordisk Inc | $18.97 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097521046 | CMS |
| Novo Nordisk Inc | $21.92 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097627239 | CMS |
| Novo Nordisk Inc | $20.75 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097653032 | CMS |
| Novo Nordisk Inc | $18.06 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097809206 | CMS |
| Novo Nordisk Inc | $21.41 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096876007 | CMS |
| Novo Nordisk Inc | $8.90 | 07/23/2024 | Education | Undisputed | 01/23/2026 | 1096865861 | CMS |
| Novo Nordisk Inc | $19.57 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097249823 | CMS |
| Novo Nordisk Inc | $21.41 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097186267 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.